|
|
Other links at Articles > Cardiology |
| 2. |
First Data on Aliskiren in Diabetic Nephropathy
|
|
|
The first trial of the new direct renin inhibitor, aliskiren, in patients with diabetic nephropathy shows that it reduces proteinuria when added to conventional treatment. But observers say this is merely a surrogate-end-point trial and definitive guidance on how to use this drug in such patients will come only from an ongoing large outcomes study, ALTITUDE. Heartwire
|
|
|
